Finance

Lists
Why is 524372 down 2.15%?
Dive Deeper
524372:BOM
Orchid Pharma Ltd
₹958.00
-2.15%
(-21.00) 1D
Oct 13, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524372...
Open
₹972.30
High
₹979.20
Low
₹947.00
Mkt. cap
57.48B
Avg. vol.
6.83K
Volume
7.32K
52-wk high
₹1,142.65
52-wk low
₹471.30
No. of employees
1K
Open
₹972.30
High
₹979.20
Low
₹947.00
Mkt. cap
57.48B
Avg. vol.
6.83K
Volume
7.32K
52-wk high
₹1,142.65
52-wk low
₹471.30
No. of employees
1K
News stories
From web sources and news partners
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees1.17K
Founded1992
Headquarters-
SectorPharmaceutical industry
Websiteorchidpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.94B
2.07B
6.59B
3.04B
Cost of goods sold
1.33B
1.43B
5.03B
2.04B
Cost of revenue
1.33B
1.43B
5.03B
2.04B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248.51M
241.28M
502.27M
280.38M
Operating expense
713.95M
715.86M
1.40B
968.16M
Total operating expenses
2.04B
2.15B
6.43B
3.01B
Operating income
-103.77M
-74.65M
163.81M
30.51M
Other non operating income
107.74M
56.09M
-238.03M
18.28M
EBT including unusual items
-57.24M
-126.14M
131.94M
32.97M
EBT excluding unusual items
-57.24M
-55.01M
54.86M
32.97M
Income tax expense
-
-
17.00K
723.00K
Effective tax rate
-
-
0.01%
2.19%
Other operating expenses
376.43M
384.29M
419.31M
578.29M
Net income
-57.24M
-126.14M
131.92M
32.24M
Net profit margin
-2.96%
-6.09%
2.00%
1.06%
Earnings per share
-1.13
-1.08
4.58
0.54
Interest and investment income
-
-
101.25M
-
Interest expense
-37.32M
-31.78M
-
-22.30M
Net interest expenses
-37.32M
-31.78M
101.25M
-22.30M
Depreciation and amortization charges
89.01M
90.29M
166.61M
109.49M
EBITDA
-15.99M
10.45M
269.63M
119.14M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps